October 19, 2010 – Opto Circuits, an Indian company that designs, develops manufactures and markets healthcare equipment and interventional products, will acquire Cardiac Science. Cardiac Science manufactures ECG and stress test systems.
October 18, 2010 - A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with an artificial heart while waiting for a matching donor heart. The patient was implanted with the SynCardia temporary Total Artificial Heart.
October 18, 2010 – Toronto General Hospital is the first Canadian medical center to implant a left-ventricular assist system (LVAS) as part of a study for patients awaiting a heart transplant. The Peter Munk Cardiac Centre used the DuraHeart LVAS, by Terumo Heart, as part of the SUSTAIN BTT study.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
St. Jude Medical Inc. said it plans to acquire AGA Medical Holdings Inc. for about $1.3 billion. The purchase will expand St. Jude’s cardiac device offerings with a portfolio of transcatheter structural heart occluders.
October 15, 2010 – The U.S. Food and Drug Administration (FDA) has approved an abbreviated new drug application (ANDA) for a generic equivalent to Novartis’ Lotrel capsules.
October 15, 2010 – Medtronic has entered into a $268 million settlement relating to its Sprint Fidelis family of defibrillation leads.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 15, 2010 – An investigational trial of Medtronic’s CoreValve transcatheter aortic valve has been approved by the U.S. Food and Drug Administration (FDA) today. The investigational device exemption (IDE) pivotal clinical trial will enroll more than 1,200 patients at 40 U.S. clinical sites.
October 14, 2010 – An injectable magnetic resonance angiography (MRA) blood pool imaging agent has been released in Canada. Ablavar, which is made by Lantheus Medical Imaging and previously marketed as Vasovist, is indicated for contrast-enhanced MRA for visualization of abdominal or limb vessels in patients with suspected or known vascular disease.
October 14, 2010 – A new round of equity financing will help launch the LipiScan IVUS Coronary Imaging System in the United States. InfraReDx raised $21 million to launch the first system to combine intravascular ultrasound (IVUS) with the company’s near infrared (NIR) spectroscopy.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 14, 2010 – A bifurcation stent maker has closed $17 million in round D financing to help it expand worldwide, pursue research and development and seek out regulatory approvals in the United States, Japan and China. TriReme Medical announced the funding, which was led by Bio*One Capital.
October 14, 2010 – A new echocardiography management program has been launched with Blue Cross and Blue Shield of Vermont (BCBCVT). American Imaging Management (AIM) will partner with BCBSVT to support more consistent use of those services. AMI has provided diagnostic imaging clinical review services for Vermont health plans since 2008.
October 13, 2010 – A new guidewire has been launched for use in challenging, small vessel peripheral angioplasty procedures. The Journey Guidewire, by Boston Scientific, is 0.014 inches and designed to address physician needs in treating arteries below the knee.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 13, 2010 – A cardiac workstation software upgrade has been released that enables healthcare professionals to digitally store and review diagnostic test data. Version 1.6.3 of Welch Allyn’s CardioPerfect Workstation maximizes workflow efficiency and simplifies electronic health record (EHR) integration in ambulatory care settings that utilize thin-client technology.
October 13, 2010 – A recall was issued for bottles of 40 mg Lipitor, due to a small number of reports of an uncharacteristic odor related to the packaging. A medical assessment has determined that the odor is not likely to cause adverse health effects. However, Pfizer recommends that anyone taking 40 mg Lipitor who experiences a strange odor should return the tablets to their pharmacist.
October 13, 2010 – The anti-obesity drug sibutramine will be withdrawn from the U.S. market after a study found it had cardiovascular safety risks. Sibutramine (Meridia), made by Abbott, is a prescription medicine used to help overweight or obese people lose weight. Abbott is voluntarily withdrawing the drug at the request of the U.S. Food and Drug Administration (FDA).